α1-acid glycoprotein (AGP)-induced platelet shape change involves the Rho/Rho kinase signalling pathway

Abstract

alpha(1)-acid glycoprotein (AGP) is an acute-phase protein that contributes to inflammation processes. The role of AGP in platelet activation and thrombosis is, however, largely unknown. Therefore, we thoroughly investigated the effects of AGP on human platelets. Platelets were isolated from healthy volunteers and subsequently exposed to AGP. Platelet responses were monitored as change in light transmission, intracellular calcium concentration, light microscopy and protein phosphorylation by Western blot. We found that AGP induced platelet shape change independently of a second release of adenine nucleotides or thromboxane A(2), and that effect was abolished by endothelium-derived platelet inhibitors such as nitric oxide (NO) and adenosine. Furthermore, AGP triggered a minor calcium response and a pronounced Rho/Rho-kinase-dependent increase in Thr696 phosphorylation of myosin phosphatase target subunit 1 (MYPT1). Moreover, the Rho/Rho-kinase inhibitor Y-27632 significantly decreased the AGP-induced shape change. The results also showed that the AGP-elicited shape change was antagonised by pretreatment with low doses of collagen and thrombospondin-1. Our results describe a novel mechanism by which AGP stimulates platelet shape change via activation of the Rho/Rho-kinase signalling pathway. Physiological important platelet inhibitors, such as NO, completely counterbalance the effect of AGP. Hence, the present study indicates that AGP directly contributes to platelet activation, which in turn might have an impact in physiological haemostasis and/or pathological thrombosis.

The neutrophil serine protease PR3 induces shape change of platelets via the Rho/Rho kinase and Ca2+ signaling pathways

“…Rho activation and minimal Ca 2+ mobilization) is not linked to formation of platelet aggregates. Interestingly, we recently showed that the acute-phase reactant alpha1-acid glycoprotein caused platelet shape change, but not secretion or aggregation, via activation of the same intracellular signaling pathways [31]. This may imply that acute inflammation is associated with priming of platelets via molecules such as PR3 and alpha1-acid glycoprotein.…”

Pulmonary thrombosis in acute organophosphate poisoning—Case report and literature overview of prothrombotic preconditioning in organophosphate toxicity

“…Moreover, there was a case report of angiography verified coronary thrombosis induced by intracoronary acetylcholine injection [38]. Experimentally, some of the OP (soman and paraoxon) poisonings involved increase synthesis of Alpha (1)-acid glycoprothein [39] which induced platelet shape change and activation, indicating the influence of OPs on hemostasis and thrombosis using this mechanism [40]. The ACh induced prothrombotic effects were potentiated in the atherosclerotic vessels [41], giving the potential to OP poisoning to increase the prorthrombotic activity and pulmonary vasoconstrictive tone in patients with comorbidities, as it was the case with our patient with a history of HTA and hyperlypidemia.…”

Orosomucoid, Carotid Plaque, and Incidence of Stroke

“…33 Ischemic stroke is a heterogeneous disease. 34,35 Large artery atherosclerosis, such as carotid plaque, is an established risk factor for cerebral infarction.…”